108 results
Page 2 of 6
6-K
EX-99.2
gicz9uy7
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.1
7tbgiugq
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
SUPPL
3hhqeclm v9
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
yrwxa2hkix3uuz9
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
qk2bq
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
1cwh aszm4amp6
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
wsp59gg
2 May 22
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
7:00am
6-K
EX-99.2
wgv5hb
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
smhuc8cthopwyuwdb
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
85jg8vvnz
5 Apr 22
Current report (foreign)
4:07pm
6-K
EX-99.1
f142rc
4 Mar 22
Report of Foreign Private Issuer for the Month of March 2022
11:32am
40-F
EX-99.1
m9tb0qbxlt
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.3
owiv8 8jgmp
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
7lv0fn93d45j
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
4lm7mkx34 8wety6zmj9
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
6on tnz2bvge0
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
48r ukzpb3f
13 Dec 21
Supplemental materials (foreign)
5:00pm
6-K
EX-99.2
iibyw7girs442oh3
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.1
rczj0nww1p6xk94
23 Aug 21
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021
7:00am
6-K
EX-99.2
14wzf6 g9
11 Aug 21
Condensed Consolidated Interim Financial Statements of
4:43pm